Artiklar med krav på offentlig åtkomst - Louis-Charles FortierLäs mer
Inte tillgängliga någonstans: 5
Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile
LH Yan, A Le Roux, K Boyapelly, AM Lamontagne, MA Archambault, ...
European journal of medicinal chemistry 143, 755-768, 2018
Krav: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Activation of the IL-1β/CXCL1/MMP-10 axis in chorioamnionitis induced by inactivated Group B Streptococcus
J Bergeron, N Gerges, C Guiraut, D Grbic, MJ Allard, LC Fortier, ...
Placenta 47, 116-123, 2016
Krav: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Suspension plasma sprayed copper-graphene coatings for improved antibacterial properties
T Aissou, J Jann, N Faucheux, LC Fortier, N Braidy, J Veilleux
Applied Surface Science 639, 158204, 2023
Krav: Natural Sciences and Engineering Research Council of Canada
RNA-based regulation in bacteria-phage interactions
M Saunier, LC Fortier, O Soutourina
Anaerobe, 102851, 2024
Krav: Agence Nationale de la Recherche
Chronic Diarrhea Caused by a Klebsiella oxytoca Toxin Producer Strain Following Antibiotic-Associated Hemorrhagic Colitis: Successful Treatment by Fecal …
MF Granger, M Kelly, LC Fortier, E Fournier, J Côté-Gravel, F Malouin, ...
Clinical Infectious Diseases 77 (12), 1700-1703, 2023
Krav: Natural Sciences and Engineering Research Council of Canada
Tillgängliga någonstans: 33
Importance of prophages to evolution and virulence of bacterial pathogens
LC Fortier, O Sekulovic
Virulence 4 (5), 354-365, 2013
Krav: Fonds de recherche du Québec - Santé
Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways
J Mulhbacher, E Brouillette, M Allard, LC Fortier, F Malouin, ...
PLoS pathogens 6 (4), e1000865, 2010
Krav: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
K Selle, JR Fletcher, H Tuson, DS Schmitt, L McMillan, GS Vridhambal, ...
MBio 11 (2), 10.1128/mbio. 00019-20, 2020
Krav: US National Institutes of Health
Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile
E Bordeleau, EB Purcell, DA Lafontaine, LC Fortier, R Tamayo, V Burrus
Journal of bacteriology 197 (5), 819-832, 2015
Krav: US National Institutes of Health
c-di-GMP Turn-Over in Clostridium difficile Is Controlled by a Plethora of Diguanylate Cyclases and Phosphodiesterases
E Bordeleau, LC Fortier, F Malouin, V Burrus
PLoS genetics 7 (3), e1002039, 2011
Krav: Fonds de recherche du Québec - Santé
Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens
O Sekulovic, M Meessen-Pinard, LC Fortier
Journal of bacteriology 193 (11), 2726-2734, 2011
Krav: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes
S Sirard, L Valiquette, LC Fortier
Journal of clinical microbiology 49 (12), 4040-4046, 2011
Krav: Fonds de recherche du Québec - Santé
Evidence of In Vivo Prophage Induction during Clostridium difficile Infection
M Meessen-Pinard, O Sekulovic, LC Fortier
Applied and environmental microbiology 78 (21), 7662-7670, 2012
Krav: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Type I toxin-antitoxin systems contribute to the maintenance of mobile genetic elements in Clostridioides difficile
J Peltier, A Hamiot, JR Garneau, P Boudry, A Maikova, E Hajnsdorf, ...
Communications biology 3 (1), 718, 2020
Krav: Agence Nationale de la Recherche
Function of the CRISPR-Cas system of the human pathogen Clostridium difficile
P Boudry, E Semenova, M Monot, KA Datsenko, A Lopatina, O Sekulovic, ...
MBio 6 (5), 10.1128/mbio. 01112-15, 2015
Krav: US National Institutes of Health, Fonds de recherche du Québec - Santé …
Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort
CN Abou Chakra, A McGeer, AC Labbé, AE Simor, WL Gold, MP Muller, ...
Clinical Infectious Diseases 61 (12), 1781-1788, 2015
Krav: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins
O Sekulovic, JR Garneau, A Néron, LC Fortier
Applied and environmental microbiology 80 (8), 2555-2563, 2014
Krav: Fonds de recherche du Québec - Santé
The Clostridium difficile cell wall protein CwpV confers phase‐variable phage resistance
O Sekulovic, M Ospina Bedoya, AS Fivian‐Hughes, NF Fairweather, ...
Molecular microbiology 98 (2), 329-342, 2015
Krav: Fonds de recherche du Québec - Santé, Natural Sciences and Engineering …
Global transcriptional response of Clostridium difficile carrying the ϕCD38-2 prophage
O Sekulovic, LC Fortier
Applied and environmental microbiology 81 (4), 1364-1374, 2015
Krav: Fonds de recherche du Québec - Santé
Prevention of Clostridium difficilespore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam
JR Garneau, L Valiquette, LC Fortier
BMC infectious diseases 14, 1-10, 2014
Krav: Fonds de recherche du Québec - Santé
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.